Fig. 4From: Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17Predicted HRQoL score trajectories. Legend: Predictions for the four dimensions of the EORTC QLQ-C30 (QL, PF, PA, and FA) according to the LMM, PMM, SM, and SPM. The solid line refers to the control fluorouracil-cisplatin regimen and the dashed line refers the experimental FOLFOX regimenBack to article page